Who Owns SYNDAX PHARMACEUTICALS INC (SNDX)? -- Institutional Holders (2026-06-30)
277 institutions reported holding $2.41B of SYNDAX PHARMACEUTICALS INC (SNDX) in SEC 13F filings for 2026-06-30. Largest institutional holders: BlackRock, Inc. ($197.2M), Kynam Capital Management, LP ($176.0M), VANGUARD GROUP INC ($144.2M), GOLDMAN SACHS GROUP INC ($128.1M), STATE STREET CORP ($123.7M). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|
| 1 | BlackRock, Inc. | $197.2M | 9.0M | Added |
| 2 | Kynam Capital Management, LP | $176.0M | 8.1M | Hold |
| 3 | VANGUARD GROUP INC | $144.2M | 6.6M | Added |
| 4 | GOLDMAN SACHS GROUP INC | $128.1M | 5.9M | Added |
| 5 | STATE STREET CORP | $123.7M | 5.7M | Added |
| 6 | BANK OF AMERICA CORP /DE/ | $88.4M | 4.0M | Trimmed |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. | $82.6M | 3.8M | Hold |
| 8 | Eversept Partners, LP | $61.2M | 2.8M | Trimmed |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $56.5M | 2.6M | Added |
| 10 | Hood River Capital Management LLC | $56.1M | 2.6M | Added |
| 11 | KINGDON CAPITAL MANAGEMENT, L.L.C. | $54.6M | 2.5M | Hold |
| 12 | FRANKLIN RESOURCES INC | $50.0M | 2.3M | Added |
| 13 | MILLENNIUM MANAGEMENT LLC | $44.9M | 2.1M | Added |
| 14 | SILVERARC CAPITAL MANAGEMENT, LLC | $41.7M | 1.9M | Added |
| 15 | UBS Group AG | $41.4M | 1.9M | Added |
| 16 | Elmind Capital, LP | $40.6M | 1.9M | Hold |
| 17 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39.1M | 1.8M | Added |
| 18 | Candriam S.C.A. | $37.0M | 1.7M | Added |
| 19 | Soleus Capital Management, L.P. | $35.6M | 1.6M | Trimmed |
| 20 | TWO SIGMA INVESTMENTS, LP | $34.5M | 1.6M | Trimmed |
| 21 | ORBIMED ADVISORS LLC | $33.7M | 1.5M | Added |
| 22 | Nuveen, LLC | $29.8M | 1.4M | Trimmed |
| 23 | MPM BIOIMPACT LLC | $29.2M | 1.3M | Trimmed |
| 24 | Aisling Capital Management LP | $28.8M | 1.3M | Hold |
| 25 | Woodline Partners LP | $27.3M | 1.3M | Hold |
Source: SEC Form 13F filings · as of 2026-06-30